CANF

Can-Fite Biopharma Ltd Sponsored ADR (Israel) (CANF)

About Can-Fite Biopharma Ltd Sponsored ADR (Israel) (CANF)

Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. Its product pipeline include Piclidenoson, Namodenoson, and CF602. The company was founded by Pnina Fishman and Ilan Cohn on September 11, 1994 and is headquartered in Petach-Tikva, Israel.

Details

Daily high
$1.50
Daily low
$1.42
Price at open
$1.48
52 Week High
$4.69
52 Week Low
$1.29
Market cap
14.7M
Dividend yield
0.00%
Volume
213,572
Avg. volume
1.2M
P/E ratio
-.80

Can-Fite Biopharma Ltd Sponsored ADR (Israel) News

Details

Daily high
$1.50
Daily low
$1.42
Price at open
$1.48
52 Week High
$4.69
52 Week Low
$1.29
Market cap
14.7M
Dividend yield
0.00%
Volume
213,572
Avg. volume
1.2M
P/E ratio
-.80